Fair Value Upside
Undervalued Stocks – Page 47
Fundamentally validated companies trading below PriceToWorth Primary Fair Value, ranked by business quality, growth, risk and large-cap or major-index credibility.
Showing 1,105–1,128 of 1,929 stocks
Page 47 of 81
Data as of
Nov 6, 2026
Criteria
At least 10% upside to PriceToWorth Primary Fair Value, Medium-or-better Primary Fair Value confidence, fundamental evidence, common equity and $100M+ market cap by default.
Ranking
Primary-Fair-Value hybrid: bounded upside, Primary Fair Value confidence, financial health, cash conversion, growth, sector-aware multiples, balance-sheet risk and Large-Cap / major-index credibility. Analyst data and component valuation models do not affect this ranking.
Data quality
Validated results require usable primary evidence and apply sector-appropriate quality checks; unavailable supporting metrics remain neutral rather than becoming zero.
Strong favorable
Favorable
Watch
Risk / negative
Neutral
↔ Scroll horizontally to compare all relevant metrics Swipe horizontally to compare all relevant metrics
Rank
Ticker
Market
Fair Value Gap
Analyst Upside
P/E
P/B
P/S
Dividend Yield
Health
Market Cap
#1,105
BXC
NYSE
10.7% Upside
Fair
33.0% Upside
—
0.8x
0.2x
—
Fair
$522.50M
#1,106
DGICA
NASDAQ
10.1% Upside
Fair
10.8% Upside
10.7x
1.1x
0.8x
4.0%
Good
$736.30M
#1,107
KODK
NYSE
59.7% Upside
Bargain
62.2% Upside
—
1.1x
0.6x
—
Good
$725.90M
#1,108
CTRI
NYSE
39.1% Upside
Undervalued
52.4% Upside
65.3x
2.2x
0.6x
—
Fair
$1.88B
#1,109
CLNE
NASDAQ
38.4% Upside
Undervalued
163.2% Upside
—
0.6x
0.8x
—
Good
$332.90M
#1,110
ONIT
NYSE
37.4% Upside
Undervalued
55.2% Upside
2.0x
0.4x
0.2x
—
Fair
$269.20M
#1,111
RITM
NYSE
37.3% Upside
Undervalued
35.4% Upside
14.7x
0.8x
1.1x
10.5%
Fair
$5.28B
#1,112
MNR
NYSE
37.2% Upside
Undervalued
69.6% Upside
16.5x
0.9x
1.3x
14.4%
Good
$1.66B
#1,113
TV
NYSE
31.6% Upside
Undervalued
60.4% Upside
—
0.2x
0.4x
—
Good
$1.23B
#1,114
HELE
NASDAQ
30.8% Upside
Undervalued
-16.2% Downside
—
1.0x
0.5x
—
Fair
$883.20M
#1,115
SDRL
NYSE
27.1% Upside
Undervalued
31.3% Upside
—
0.9x
1.7x
—
Fair
$2.53B
#1,116
DOCN
NYSE
25.7% Upside
Undervalued
137.8% Upside
243.5x
5.9x
7.6x
—
Fair
$8.34B
#1,117
GRNT
NYSE
25.4% Upside
Undervalued
87.4% Upside
—
1.1x
1.3x
9.5%
Fair
$616.00M
#1,118
PDS
NYSE
23.8% Upside
Undervalued
15.0% Upside
—
1.0x
0.8x
—
Fair
$1.13B
#1,119
NVCR
NASDAQ
23.5% Upside
Undervalued
89.8% Upside
—
4.5x
2.2x
—
Fair
$1.58B
#1,120
BYD
NYSE
22.6% Upside
Undervalued
13.5% Upside
10.8x
2.2x
1.3x
1.0%
Good
$5.45B
#1,121
CGEN
NASDAQ
22.1% Upside
Undervalued
139.6% Upside
5.2x
2.0x
2.5x
—
Excellent
$182.80M
#1,122
BIPC
NYSE
20.2% Upside
Undervalued
26.6% Upside
—
—
1.3x
4.7%
Good
$4.66B
#1,123
ATNI
NASDAQ
17.3% Upside
Fair
159.5% Upside
2.5x
0.7x
0.5x
4.4%
Good
$395.30M
#1,124
GSBC
NASDAQ
16.1% Upside
Fair
-3.4% Downside
13.7x
1.4x
3.8x
2.1%
Fair
$867.60M
#1,125
BTE
NYSE
14.1% Upside
Fair
—
—
1.9x
2.5x
1.5%
Good
$2.96B
#1,126
CMT
NYSE
13.8% Upside
Fair
42.5% Upside
25.8x
1.1x
0.6x
—
Fair
$180.10M
#1,127
HTH
NYSE
12.1% Upside
Fair
10.5% Upside
14.8x
1.0x
1.7x
2.3%
Fair
$2.09B
#1,128
BCML
NASDAQ
11.4% Upside
Fair
7.0% Upside
36.3x
1.0x
3.6x
3.8%
Fair
$334.50M
No company or ticker on this page matches your search.